Vicus Capital raised its position in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 76.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,114 shares of the enterprise software provider’s stock after buying an additional 2,646 shares during the quarter. Vicus Capital’s holdings in Oracle were worth $1,720,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Darwin Wealth Management LLC boosted its stake in Oracle by 130.0% in the 3rd quarter. Darwin Wealth Management LLC now owns 115 shares of the enterprise software provider’s stock worth $32,000 after purchasing an additional 65 shares during the period. Winnow Wealth LLC purchased a new stake in shares of Oracle in the second quarter valued at $28,000. Financial Consulate Inc. acquired a new stake in shares of Oracle in the third quarter worth $37,000. Corundum Trust Company INC acquired a new position in Oracle during the third quarter valued at $39,000. Finally, Kilter Group LLC purchased a new stake in Oracle in the 2nd quarter worth about $30,000. 42.44% of the stock is owned by hedge funds and other institutional investors.
Key Oracle News
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Jefferies reaffirmed a Buy rating and a $400 price target, citing confidence in Oracle’s positioning for AI infrastructure — a signal that institutional research sees meaningful upside from Oracle’s cloud/AI strategy. Jefferies’ $400 Oracle (ORCL) Target Reflects Confidence in AI Infrastructure
- Positive Sentiment: Multiple analysts/upgrades remain bullish on ORCL (coverage noted in roundups), reinforcing demand-side expectations for AI/cloud revenue growth and helping lift the stock. Upgrades: Analysts are Still Bullish on Nvidia (NVDA), Crowdstrike (CRWD) and Oracle (ORCL) Upside
- Positive Sentiment: Oracle announced a healthcare customer win: Community Memorial Hospital will implement Oracle Health Foundation EHR and the Oracle Health Clinical AI Agent — a tangible enterprise adoption case for Oracle’s AI-driven healthcare stack. Customer wins help validate commercial traction and recurring revenue potential. Community Memorial Hospital Chooses Oracle Health to Enhance Patient Care and Power Operational Excellence
- Positive Sentiment: Oracle unveiled an AI-driven Retail Supply Chain Collaboration solution at NRF — another product rollout that supports cross-selling into retail customers and reinforces the company’s AI/cloud monetization narrative. Retailers Help Mitigate Risk with Oracle’s AI-Driven Supply Chain Collaboration
- Positive Sentiment: MarketBeat and other pieces highlight Oracle as a leading cross-cloud operator with strong hyperscaler-driven gains and a large RPO pipeline — reinforcing bullish forward-growth expectations tied to AI/cloud infrastructure. 5 AI Stocks Positioned to Win, No Matter What
- Negative Sentiment: High-profile investor Michael Burry has taken short positions and put options on Oracle, publicly criticizing its cloud strategy and highlighting ~ $95B of debt tied to data-center expansion — a headline risk that fuels selling pressure and raises governance/financial-concern narratives. Oracle (ORCL) Stock: Burry Takes Short Position on Database Company
Oracle Stock Performance
Oracle (NYSE:ORCL – Get Free Report) last announced its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The firm had revenue of $16.06 billion during the quarter, compared to analysts’ expectations of $16.19 billion. During the same quarter in the prior year, the business earned $1.47 earnings per share. The company’s revenue was up 14.2% on a year-over-year basis. As a group, equities research analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 23rd. Investors of record on Friday, January 9th will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, January 9th. This represents a $2.00 annualized dividend and a yield of 1.0%. Oracle’s dividend payout ratio is presently 37.59%.
Wall Street Analyst Weigh In
Several research firms have weighed in on ORCL. BMO Capital Markets lowered their target price on Oracle from $355.00 to $270.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Robert W. Baird dropped their price objective on shares of Oracle from $365.00 to $315.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 18th. Redburn Partners set a $175.00 target price on shares of Oracle in a research note on Thursday, September 25th. Royal Bank Of Canada dropped their price target on shares of Oracle from $250.00 to $195.00 and set a “sector perform” rating on the stock in a research note on Monday, January 5th. Finally, Cantor Fitzgerald cut their price objective on Oracle from $400.00 to $320.00 and set an “overweight” rating for the company in a report on Thursday, December 11th. Four analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Oracle has a consensus rating of “Moderate Buy” and a consensus price target of $305.50.
Read Our Latest Report on ORCL
Insider Transactions at Oracle
In other news, Director Jeffrey Berg sold 49,365 shares of the stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $283.02, for a total value of $13,971,282.30. Following the completion of the sale, the director directly owned 151,999 shares of the company’s stock, valued at approximately $43,018,756.98. This represents a 24.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Clayton M. Magouyrk sold 10,000 shares of the company’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $192.52, for a total transaction of $1,925,200.00. Following the transaction, the chief executive officer owned 144,030 shares of the company’s stock, valued at approximately $27,728,655.60. The trade was a 6.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 126,588 shares of company stock worth $33,155,596. Insiders own 40.90% of the company’s stock.
Oracle Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Featured Articles
- Five stocks we like better than Oracle
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
